Ivory soap is renowned for being 99.44 percent pure. In the advertising realm, that is an impressive percentage. In corporate liability and risk management, however, 99 percent effectiveness and safety may not be impressive enough.

In my career handling and managing claims — helping policyholders who have been the target of lawsuits — I often hear clients insist that they have a strong legal defense because an accident or an adverse outcome is "statistically insignificant." For example, when dealing with prescription drugs or medical liabilities, perhaps only a few dozen patients out of 10,000 have a fatal reaction. Maybe only 66 out of a million are adversely affected. In this calculus, it is easy to rush to judgment in dismissing a plaintiff's liability argument. One could say the claim is bogus and has no merit, anticipating a slam-dunk trial victory.

Risk managers defending such suits must exercise caution with this argument, which juries may simply find unconvincing. In bodily injury claims, a patient's appearance and soft and squishy sympathy factors may hold sway. If you, your child, or your spouse suffers an adverse outcome or has a severe accident, then you would likely find little solace in knowing that the incident is "statistically insignificant."

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.